SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227-1232.
  • 2
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233-1241.
  • 3
    Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995; 333: 1456-1461.
  • 4
    van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000; 92: 1143-1150.
  • 5
    Arriagada R, Le MG, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996; 14: 1558-1564.
  • 6
    Touboul E, Buffat L, Belkacemi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999; 43: 25-38.
  • 7
    Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of Stage I and II breast cancer. N Engl J Med. 1995; 332: 907-911.
  • 8
    Haffty BG, Reiss M, Beinfield M, et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol. 1996; 14: 52-57.
  • 9
    Mirza NQ, Vlastos G, Meric F, et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol. 2002; 9: 256-65.
  • 10
    Fisher B, Gunduz N, Costantino J, et al. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Cancer. 1991; 68: 1465-1475.
  • 11
    Elkhuizen PH, van de Vijver MJ, Hermans J, et al. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys. 1998; 40: 859-867.
  • 12
    Cowen D, Jacquemier J, Houvenaeghel G, et al. Local and distant recurrence after conservative management of “very low-risk” breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys. 1998; 41: 801-807.
  • 13
    Rouzier R, Extra JM, Carton M, et al. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol. 2001; 19: 3828-3835.
  • 14
    Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991; 338: 327-331.
  • 15
    della Rovere GQ, Benson JR. Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis? Lancet Oncol. 2002; 3: 183-187.
  • 16
    Danoff BF, Pajak TF, Solin LJ, et al. Excisional biopsy, axillary node dissection and definitive radiotherapy for Stages I and II breast cancer. Int J Radiat Oncol Biol Phys. 1985; 11: 479-483.
  • 17
    Calle R, Vilcoq JR, Zafrani B, et al. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys. 1986; 12: 873-878.
  • 18
    Delouche G, Bachelot F, Premont M, et al. Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys. 1987; 13: 29-34.
  • 19
    Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989; 14: 177-184.
  • 20
    Rayter Z, Gazet JC, Ford HT, et al. Comparison of conservative surgery and radiotherapy with mastectomy in the treatment of early breast cancer. Eur J Surg Oncol. 1990; 16: 486-492.
  • 21
    Veronesi U, Saccozzi R, Del Vecchio M,et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981; 305: 6-11.
  • 22
    Montague ED. Conservation surgery and radiation therapy in the treatment of operable breast cancer. Cancer. 1984; 53: 700-704.
  • 23
    Lichter AS, Lippman ME, Danforth DN Jr., et al. Mastectomy versus breast-conserving therapy in the treatment of Stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol. 1992; 10: 976-983.
  • 24
    Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000; 18: 1668-1675.
  • 25
    Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001; 12: 997-1003.
  • 26
    Fisher B, Gebhardt MC. The evolution of breast cancer surgery: past, present, and future. Semin Oncol. 1978; 5: 385-394.
  • 27
    Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994; 74: 1746-1751.
  • 28
    Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for Stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001; 19: 1688-1697.
  • 29
    DiBiase SJ, Komarnicky LT, Heron DE, et al. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. Int J Radiat Oncol Biol Phys. 2002; 53: 680-6.
  • 30
    Koscielny S, Tubiana M. The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys. 1999; 43: 11-24.
  • 31
    Gelman R, Harris JR. Editorial comment on Koscielny S, Tubiana M. “The link between local recurrence and distant metastasis in human breast cancer.” Int J Radiat Oncol Biol Phys. 1999; 43: 7-9.
  • 32
    Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989; 320: 822-828.
  • 33
    Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996; 88: 1659-1664.
  • 34
    Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996; 348: 708-713.
  • 35
    Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001; 345: 1378-1387.
  • 36
    Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002; 20: 4141-4149.
  • 37
    Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000; 355: 1757-1770.
  • 38
    Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997; 337: 949-955.
  • 39
    Fisher ER, Anderson S, Redmond C, et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol. 1992; 8: 161-166.
  • 40
    Hurd TC, Sneige N, Allen PK, et al. Impact of extensive intraductal component on recurrence and survival in patients with Stage I or II breast cancer treated with breast conservation therapy. Ann Surg Oncol. 1997; 4: 119-124.